Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05130866
Title Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas (POPLAR-NF2)
Acronym POPLAR-NF2
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Recursion Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.